Vincent Martin Selected Research

JMV4463

2/2016	Structure-Activity Relationships of JMV4463, a Vectorized Cathepsin D Inhibitor with Antiproliferative Properties: The Unique Role of the AMPA-Based Vector.
10/2013	Dipeptide mimic oligomer transporter mediates intracellular delivery of Cathepsin D inhibitors: a potential target for cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent Martin Research Topics

Disease

14	Migraine Disorders (Migraine) 06/2022 - 04/2003
7	Pain (Aches) 11/2022 - 10/2004
5	Headache (Headaches) 12/2018 - 04/2003
4	Fatigue 01/2020 - 11/2009
3	Neoplasms (Cancer) 01/2019 - 10/2013
2	Inflammation (Inflammations) 05/2022 - 02/2011
1	Muscle Spasticity (Spastic) 06/2022
1	Dysbiosis 05/2022
1	Crohn Disease (Crohn's Disease) 05/2022
1	Obesity 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Insulin Resistance 01/2022
1	Overweight 01/2022
1	Sarcopenia 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020
1	Myocarditis (Carditis) 01/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019
1	Headache Disorders (Headache Syndromes) 12/2018
1	Dystonia (Limb Dystonia) 01/2018
1	Memory Disorders (Memory Loss) 01/2017
1	Cognitive Dysfunction 01/2017
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Muscular Atrophy (Muscle Atrophy) 01/2013
1	Dizziness (Lightheadedness) 04/2011
1	Sleepiness 04/2011
1	Tremor (Tremors) 04/2011
1	Nausea 04/2011
1	Dysmenorrhea (Menstrual Pain) 05/2010
1	Shock 04/2008
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 04/2008
1	Raynaud Disease (Raynaud's Disease) 04/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2004
1	Ischemia 05/2004

Drug/Important Bio-Agent (IBA)

5	Tryptamines (Triptans)IBA 09/2020 - 05/2004
3	Botulinum Toxins (Botulinum Toxin)IBA 06/2022 - 01/2018
3	TabletsIBA 06/2021 - 02/2008
3	rizatriptan (Maxalt)FDA Link 02/2008 - 10/2004
2	incobotulinumtoxinA FDA Link 11/2022 - 01/2022
2	eptinezumabIBA 06/2022 - 01/2022
2	LipidsIBA 05/2022 - 01/2022
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 09/2020
2	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 01/2019
2	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 09/2020 - 04/2011
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 01/2017
2	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2017
2	pepstatin (pepstatin A)IBA 02/2016 - 10/2013
2	JMV4463IBA 02/2016 - 10/2013
1	Type A Botulinum Toxins (Botox)FDA Link 11/2022
1	Lipocalin-2IBA 05/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2022
1	CalciumIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	EndocannabinoidsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ErgotaminesIBA 09/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020
1	galcanezumabIBA 01/2020
1	Calcitonin Gene-Related PeptideIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Serotonin ReceptorsIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2019
1	CarcinogensIBA 01/2019
1	GlucocorticoidsIBA 01/2019
1	CytokinesIBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	agomelatine (S20098)IBA 01/2017
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 02/2016
1	statineIBA 02/2016
1	Aspartic Acid ProteasesIBA 10/2013
1	Cathepsin DIBA 10/2013
1	DipeptidesIBA 10/2013
1	Whey ProteinsIBA 01/2013
1	Caseins (Casein)FDA Link 01/2013
1	Therapeutic UsesIBA 04/2012
1	Testosterone (Sustanon)FDA Link 04/2012
1	Ibuprofen (Motrin)FDA LinkGeneric 04/2011
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2011
1	telcagepantIBA 04/2011
1	C-Reactive ProteinIBA 02/2011
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2011
1	MyoglobinIBA 02/2011
1	Sumatriptan (Imigran)FDA LinkGeneric 05/2010
1	Naproxen (Naprosyn)FDA LinkGeneric 05/2010
1	ProstaglandinsIBA 05/2010
1	Potassium Chloride FDA LinkGeneric 11/2009
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2009
1	Glucose (Dextrose)FDA LinkGeneric 04/2008
1	Pain-FreeIBA 10/2004

Therapy/Procedure

7	Therapeutics 06/2021 - 04/2003
2	Treatment Delay 06/2006 - 05/2005
1	Intravenous Infusions 01/2022
1	Resistance Training 01/2022
1	High-Protein Diet 01/2021
1	Polypharmacy 12/2018
1	Transcranial Magnetic Stimulation 06/2014
1	Injections 11/2009
1	Aftercare (After-Treatment) 05/2005